90-day Readmission rate | Unadjusted model | Adjusted modela | P for interaction | ||||
---|---|---|---|---|---|---|---|
AKI (n = 24,833) | Non-AKI (n = 332,157) | HR (95% CI) | P-value | HR (95% CI) | P-value | ||
Overall (n = 356,990) | 39.7% | 31.0% | 1.35 (1.32–1.38) | < 0.001 | 1.03 (1.00–1.05) | 0.04 | |
Age category | |||||||
40–64 years (n = 122,362) | 37.6% | 27.8% | 1.43 (1.36–1.50) | < 0.001 | 1.00 (0.95–1.06) | 0.86 | 0.10 |
≥ 65 years (n = 234,628) | 40.2% | 32.8% | 1.29 (1.26–1.32) | < 0.001 | 1.03 (1.00–1.06) | 0.03 | |
Sexb | |||||||
Men (n = 149,333) | 38,9% | 32.2% | 1.26 (1.22–1.29) | < 0.001 | 0.99 (0.96–1.03) | 0.59 | 0.06 |
Women (n = 207,436) | 40.5% | 30.2% | 1.43 (1.39–1.48) | < 0.001 | 1.06 (1.02–1.09) | 0.001 | |
Chronic kidney diseasec | |||||||
Chronic kidney disease (n = 47,999) | 43.0% | 40.9% | 1.06 (1.03–1.09) | 0.001 | 0.98 (0.95–1.02) | 0.21 | < 0.001 |
No chronic kidney disease (n = 308,991) | 35.7% | 29.9% | 1.22 (1.18–1.26) | < 0.001 | 1.04 (1.00–1.07) | 0.04 |